医中誌リンクサービス


文献リスト

1)Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S1-45
PubMed CrossRef
医中誌リンクサービス
2)Graham R, Mancher M, Wolman DM, et al. Clinical Practice Guidelines We Can Trust. Washington, D.C.: National Academy of Sciences; 2011
医中誌リンクサービス
3)National Lipid Association. NLA Statement on the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. 2013; https://www.lipid.org/nla/2013-accaha-guideline-treatment-blood-cholesterol-reduce-atherosclerotic-cardiovascular-risk
医中誌リンクサービス
4)Jacobson TA, Ito MK, Maki KC, et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1- executive summary. J Clin Lipidol. 2014; 8: 473-88
PubMed CrossRef
医中誌リンクサービス
5)American Association of Clinical Endcrinologists. AACE Does Not Endorse AHA/ACC Lipid and Obesity Guidelines. 2013; http://www.endocrineweb.com/professional/obesity/aace-does-not-endorse-ahaacc-lipid-obesity-guidelines
医中誌リンクサービス
6)Ridker PM, Cook NR. Statins: new American guidelines for prevention of cardiovascular disease. Lancet. 2013; 382: 1762-5
PubMed CrossRef
医中誌リンクサービス
7)American Diabetes Association. (8) Cardiovascular disease and risk management. Diabetes Care. 2015; 38 Suppl: S49-57
PubMed
医中誌リンクサービス
8)Expert Dyslipidemia Panel of the International Atherosclerosis Society Panel members. An International Atherosclerosis Society Position Paper: global recommendations for the management of dyslipidemia--full report. J Clin Lipidol. 2014; 8: 29-60
PubMed CrossRef
医中誌リンクサービス
9)Ray KK, Kastelein JJ, Boekholdt SM, et al. The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain: a comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011. Eur Heart J. 2014; 35: 960-8
PubMed CrossRef
医中誌リンクサービス
10)日本動脈硬化学会.ACC/AHAガイドラインに対する日本動脈硬化学会の見解.http://www.j-athero.org/outline/guideline_comment.html
医中誌リンクサービス
11)Kavousi M, Leening MJ, Nanchen D, et al. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort. JAMA. 2014; 311: 1416-23
PubMed CrossRef
医中誌リンクサービス
12)Pursnani A, Mayrhofer T, Ferencik M, et al. The 2013 ACC/AHA cardiovascular prevention guidelines improve alignment of statin therapy with coronary atherosclerosis as detected by coronary computed tomography angiography. Atherosclerosis. 2014; 237: 314-8
PubMed CrossRef
医中誌リンクサービス
13)Pursnani A, Massaro JM, D?Agostino RB Sr, et al. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events. JAMA. 2015; 314: 134-41
PubMed CrossRef
医中誌リンクサービス
14)Johnson KM, Dowe DA. Accuracy of statin assignment using the 2013 AHA/ACC Cholesterol Guideline versus the 2001 NCEP ATP III guideline: correlation with atherosclerotic plaque imaging. J Am Coll Cardiol. 2014; 64: 910-9
PubMed CrossRef
医中誌リンクサービス
15)Pandya A, Sy S, Cho S, et al. Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease. JAMA. 2015; 314: 142-50
PubMed CrossRef
医中誌リンクサービス
16)Tsukamoto K. Treatment of dyslipidemia in diabetes. Should the lipid-management protocol which the ADA 2015 guideline recommends be used for Japanese as a reference? Diabetol Int. published ahead on line. DOI 10.1007/s13340-015-0225-z
医中誌リンクサービス


NPO医学中央雑誌刊行会
https://www.jamas.or.jp/
info@jamas.or.jp